Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Polyoma virus disrupts ARF signaling to p53

Abstract

Polyoma virus (Py) differs from other small DNA tumor viruses in not encoding a protein that inactivates p53. The complete Py early region encoding the large T-antigen (PyLT), middle T-antigen (PyMT) and small T-antigen (PyST) will transform primary rodent cells and REF52 cells, but PyMT, the main Py oncogene, by itself will only transform these cells when p53 or ARF is inactivated. We have related Py oncogene cooperation with the effects of the Py T-antigens on the ARF-p53 signaling pathway. PyMT activates an ARF-induced p53-mediated block to cell division explaining the inability of PyMT alone to generate dividing transformed cells. In contrast, in REF52 cells transformed by the whole Py early region (PyREF52), ARF is upregulated but p53 is not activated. Thus PyLT and/or PyST negates the PyMT-induced ARF-mediated block to cell division by disrupting the signaling pathway from ARF to p53. Although there is no detectable interaction or co-localization of endogenous ARF (nucleoli) and MDM2 (nucleoplasm) in PyREF52 cells, expression of transfected ectopic ARF results in an MDM2/ARF interaction and sequestration of MDM2 into the nucleoli. Sequestration of MDM2 by ARF in the nucleoli is not essential for a p53 response in REF52 cells as activation of Raf in REF52Raf-ER cells results in an ARF-induced p53-mediated cell cycle block in the absence of a detectable ARF-MDM2 interaction. Py may provide new insights into the cellular ARF-p53 signaling pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR . 1992 Proc. Natl. Acad. Sci. USA 89: 4549–4553

  • Courtneidge SA, Smith AE . 1983 Nature 303: 435–439

  • Cuzin F . 1984 Biochim. Biophys. Acta 781: 193–204

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442

  • Dilworth SM . 1990 Semin. Cancer Biol. 1: 407–414

  • Duro D, Bernard O, Della Valle V, Berger R, Larsen CJ . 1995 Oncogene 11: 21–29

  • Feinberg AP, Vogelstein B . 1984 Anal. Biochem. 137: 266–267

  • Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299

  • Honda R, Yasuda H . 1999 EMBO J. 18: 22–27

  • Kannan K, Munirajan AK, Krishnamurthy J, Bhuvarahamurthy V, Mohanprasad BK, Panishankar KH, Tsuchida N, Shanmugam G . 2000 Int, J. Oncol. 16: 585–590

  • Kubbutat MH, Jones SN, Vousden KH . 1997 Nature 387: 299–303

  • Kurokawa K, Tanaka T, Kato J . 1999 Oncogene 18: 2718–2727

  • Lin AW, Lowe SW . 2001 Proc. Natl. Acad. Sci. USA 98: 5025–5030

  • Llanos S, Clark PA, Rowe J, Peters G . 2001 Nature Cell Biol. 3: 445–452

  • Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H . 1997 Genes Dev 11: 663–677

  • Mansur CP, Marcus B, Dalal S, Androphy EJ . 1995 Oncogene 10: 457–465

  • Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D . 1995 Cancer Res. 55: 2995–2997

  • Mayo LD, Turchi JJ, Berberich SJ . 1997 Cancer Res. 57: 5013–5016

  • Meek DW . 1998 Int. J. Radiat. Biol. 74: 729–737

  • Midgley CA, Lane DP . 1997 Oncogene 15: 1179–1189

  • Mietz JA, Unger T, Huibregtse JM, Howley PM . 1992 EMBO J. 11: 5013–5020

  • Mor O, Read M, Fried M . 1997 Oncogene 15: 3113–3119

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B . 1993 Nature 362: 857–860

  • Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM . 1990 Cell 60: 167–176

  • Palmero I, Pantoja C, Serrano M . 1998 Nature 395: 125–126

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA . 1998 Cell 92: 713–723

  • Quelle DE, Zindy F, Ashmun RA, Sherr CJ . 1995 Cell 83: 993–1000

  • Rassoulzadegan M, Cowie A, Carr A, Glaichenhaus N, Kamen R, Cuzin F . 1982 Nature 300: 713–718

  • Rassoulzadegan M, Naghashfar Z, Cowie A, Carr A, Grisoni M, Kamen R, Cuzin F . 1983 Proc. Natl. Acad. Sci. USA 80: 4354–4358

  • Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A . 1995 Cancer Res. 55: 2988–2994

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G . 1998 EMBO J. 17: 5001–5014

  • Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG, Belinsky SA . 1997 Mol. Cell. Biol. 17: 1366–1374

  • Tao W, Levine AJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6937–6941

  • Walter G, Ruediger R, Slaughter C, Mumby M . 1990 Proc. Natl. Acad. Sci. USA 87: 2521–2525

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D . 1999 Nat. Cell. Biol. 1: 20–26

  • Yew PR, Berk AJ . 1992 Nature 357: 82–85

  • Zhang Y, Xiong Y . 1999 Mol. Cell 3: 579–591

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433

Download references

Acknowledgements

We would like to thank Drs Gordon Peters, Frank McCormick and Haiyan Jiang for their helpful advice and comments during the preparation of this manuscript and the course of the research.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lomax, M., Fried, M. Polyoma virus disrupts ARF signaling to p53. Oncogene 20, 4951–4960 (2001). https://doi.org/10.1038/sj.onc.1204717

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1204717

Keywords

This article is cited by

Search

Quick links